Catheter-based renal denervation for treatment of resistant hypertension

• Main Authors: Emine Hatipoglu, Albert Ferro
• Format: Article
• Language: English
• Published: SAGE Publishing 2013-05-01
• Series: JRSM Cardiovascular Disease
• Online Access: https://doi.org/10.1177/2048004013486634

Hypertension is a common disease associated with important cardiovascular complications. Persistent blood pressure of 140/90 or higher despite combined use of a reninangiotensin system blocker, calcium channel blocker and a diuretic at highest tolerated doses constitutes resistant hypertension. Excess sympathetic activity plays an important pathogenic role in resistant hypertension in addition to contributing to the development of metabolic problems, in particular diabetes. Reduction of renal sympathetic activity by percutaneous catheter-based radiofrequency ablation via the renal arteries has been shown in several studies to decrease blood pressure in patients with resistant hypertension, and importantly is largely free of significant complications. However, longer term follow-up is required to confirm both long-term safety and efficacy.